CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 163 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,788 | -59.2% | 392 | -49.7% | 0.00% | – |
| Q2 2023 | $26,467 | +52.0% | 780 | +61.2% | 0.00% | – |
| Q1 2023 | $17,414 | -19.3% | 484 | 0.0% | 0.00% | – |
| Q4 2022 | $21,571 | +978.6% | 484 | +456.3% | 0.00% | – |
| Q3 2022 | $2,000 | -33.3% | 87 | -13.0% | 0.00% | – |
| Q2 2022 | $3,000 | -83.3% | 100 | -90.0% | 0.00% | – |
| Q4 2020 | $18,000 | +20.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2020 | $15,000 | – | 1,000 | +1165.8% | 0.00% | – |
| Q3 2019 | $0 | – | 79 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 79 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 79 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 1,605,390 | $71,552,232 | 10.98% |
| Octagon Capital Advisors LP | 761,398 | $33,935,509 | 5.28% |
| TSP Capital Management Group, LLC | 269,895 | $12,029,225 | 4.50% |
| Redmile Group, LLC | 1,977,451 | $88,134,991 | 3.60% |
| COMMODORE CAPITAL LP | 495,823 | $22,099 | 3.33% |
| Tri Locum Partners LP | 176,109 | $7,849,000 | 3.18% |
| ACUTA CAPITAL PARTNERS, LLC | 115,000 | $5,125,550 | 3.15% |
| Ikarian Capital, LLC | 267,476 | $11,921,406 | 2.88% |
| RTW INVESTMENTS, LP | 3,084,215 | $137,463,463 | 2.81% |
| Eversept Partners, LP | 558,774 | $24,904,557 | 2.18% |